Entering text into the input field will update the search result below

Quoin stock rises after expanding distribution deal with ER-Kim for QRX003

Mar. 01, 2022 11:49 AM ETQuoin Pharmaceuticals, Ltd. (QNRX)By: Ravikash, SA News Editor

Businessman Signing Digital Contract On Tablet Using Stylus Pen

ilkercelik/E+ via Getty Images

  • Quoin Pharmaceuticals (QNRX +0.9%) extended its exclusive distribution agreement with ER-Kim to six additional countries for QRX003, to treat Netherton Syndrome.
  • Under the terms of the revenue sharing agreement, which was initially announced in February, ER-Kim (a partner for biotech companies

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.